Text Size
1332 studies found for:    "Ovarian Neoplasms"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed A Study of Trabectedin in Patients With Advanced Ovarian Cancer
Conditions: Ovarian Neoplasms;   Endocrine Gland Neoplasms;   Neoplasms by Site;   Neoplasms;   Ovarian Diseases;   Adnexal Diseases;   Genital Diseases, Female
Interventions: Drug: Trabectedin;   Drug: Dexamethasone
22 Unknown † Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial
Condition: Ovarian Neoplasms
Intervention: Procedure: neoadjuvant chemotherapy (Carboplatin/Docetaxel)
23 Recruiting Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
24 Completed Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: OSI-211 (Liposomal Lurtotecan)
25 Completed Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Conditions: Breast Neoplasms;   Ovarian Neoplasms
Intervention:
26 Completed A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment
Conditions: Ovarian Cancer;   Epithelial Ovarian Cancer;   Fallopian Tube Cancer
Interventions: Drug: belinostat;   Drug: Paclitaxel;   Drug: Carboplatin
27 Terminated Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Conditions: Neoplasms;   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Primary Peritoneal Neoplasm
Interventions: Biological: KHK2866;   Drug: Gemcitabine and Carboplatin;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin
28 Completed
Has Results 		Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites
Conditions: Ovarian Neoplasms;   Ascites
Interventions: Drug: aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®);   Drug: Placebo
29 Recruiting 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients
Conditions: Ovarian Neoplasms;   Ovarian Diseases;   Adnexal Diseases;   Pancreatic Neoplasms;   Digestive System Neoplasms;   Digestive System Diseases;   Pancreatic Diseases
Intervention: Drug: 89Zr-MMOT0530A
30 Recruiting Activity, Tolerability, Safety of Temsirolimus in Women With Ovarian Cancer Who Progressed During Previous Platinum Chemotherapy or Within 6 Months After Therapy or Advanced Endometrial Carcinoma
Conditions: Genital Diseases, Female;   Ovarian Diseases;   Ovarian Neoplasms;   Endometrial Neoplasms
Intervention: Drug: Temsirolimus
31 Active, not recruiting Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: AZD2281;   Drug: Liposomal Doxorubicin
32 Terminated CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy
Condition: Ovarian Neoplasms
Interventions: Drug: CAELYX;   Drug: Paclitaxel HCl
33 Completed Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients
Condition: Ovarian Neoplasms
Intervention: Drug: Carboplatin plus Celecoxib
34 Completed
Has Results 		Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Primary Peritoneal Neoplasms
Intervention: Drug: Pegylated L-Asparaginase
35 Active, not recruiting Lymphadenectomy In Ovarian Neoplasms
Condition: Ovarian Cancer
Interventions: Procedure: No Lymphadenectomy (LNE);   Procedure: Lymphadenectomy (LNE)
36 Completed Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma
Condition: Ovarian Neoplasms
Intervention:
37 Completed Pharmacogenomics of Paclitaxel in Ovarian Cancer
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms
Intervention:
38 Completed Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: docetaxel and cisplatin
39 Unknown † Pharmacogenomics of Paclitaxel in Ovarian Cancer
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms
Intervention:
40 Not yet recruiting Salvage Ovarian FANG Vaccine + Carboplatinum
Conditions: Stage III Ovarian Cancer;   Stage IV Ovarian Cancer
Interventions: Biological: Vaccine: FANG™ Vaccine;   Drug: Carboplatinum
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years